Asia Public Health Care Expansion Hinges On Cost Control Solutions
This article was originally published in PharmAsia News
Asia can avoid blowing budgets by focusing on preventative care as an unprecedented increase in public spending on health care gains momentum in developing countries such as Indonesia and the Philippines.
You may also be interested in...
Pricing And Commercial Strategies For Emerging Markets Need To Be Built Into Drug Development Programs Early - DIA Conference
CHICAGO - Emerging markets represent a plethora of opportunity for multinational pharma companies, but they also represent a confusing mix of pricing and reimbursement policies that change rapidly and are not always clear
PharmAsia News looks ahead at 2015 to highlight expected trends and events shaping the biomedical community in Southeast Asia.
Southeast Asia in 2014 saw a continued push by several nations in the region to ink a Trans-Pacific Partnership pact that would potentially have a major impact on biological drugs. Also manufacturing and distribution saw a leap in the hub of Singapore as governments in the region ramped-up health spending.